CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Exercise or conversion CEO and President acquired 287,000 shares (option exercise)
- 4 Grant or award CCO acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company SVP, Chief Medical Officer returned 4,409 shares (to the company)
- 4 Returned to the company SVP, Chief Business Officer returned 11,909 shares (to the company)
- 4 Returned to the company SVP, CLO & Secretary returned 11,929 shares (to the company)
- 4 Returned to the company SVP, Chief Development Officer returned 6,075 shares (to the company)
- 4 Returned to the company SVP, CFO & Treasurer returned 13,148 shares (to the company)
- 4 Grant or award SVP, Chief Development Officer acquired 30,000 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 80,000 shares (grant or award)
- 4 Grant or award SVP, Chief Business Officer acquired 65,000 shares (grant or award)
Page 10 of 19 · 378 filings